Search by Drug Name or NDC

    NDC 71558-0590-28 ARIKAYCE 590 mg/8.4mL Details

    ARIKAYCE 590 mg/8.4mL

    ARIKAYCE is a RESPIRATORY (INHALATION) SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Insmed Incorporated. The primary component is AMIKACIN.

    Product Information

    NDC 71558-0590
    Product ID 71558-590_6234782d-94c1-428b-b34b-c5d0db96d9d7
    Associated GPIs 07000010121830
    GCN Sequence Number 079020
    GCN Sequence Number Description amikacin liposomal/neb.accessr VIAL-NEB 590 MG/8.4 INHALATION
    HIC3 W1F
    HIC3 Description AMINOGLYCOSIDE ANTIBIOTICS
    GCN 45435
    HICL Sequence Number 045298
    HICL Sequence Number Description AMIKACIN SULFATE LIPOSOMAL WITH NEBULIZER ACCESSORIES
    Brand/Generic Brand
    Proprietary Name ARIKAYCE
    Proprietary Name Suffix n/a
    Non-Proprietary Name Amikacin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SUSPENSION
    Route RESPIRATORY (INHALATION)
    Active Ingredient Strength 590
    Active Ingredient Units mg/8.4mL
    Substance Name AMIKACIN
    Labeler Name Insmed Incorporated
    Pharmaceutical Class Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA207356
    Listing Certified Through 2024-12-31

    Package

    NDC 71558-0590-28 (71558059028)

    NDC Package Code 71558-590-28
    Billing NDC 71558059028
    Package 28 VIAL in 1 CARTON (71558-590-28) / 8.4 mL in 1 VIAL
    Marketing Start Date 2018-10-12
    NDC Exclude Flag N
    Pricing Information N/A